Increasing circulating inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1 and IL-6, has been observed in patients with heart failure, which may predict clinical outcomes, but the application of these cytokines is limited by the low circulating volumes and expensive assays (18–21). The gene discussed is IL6; the disease is heart failure.